VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 129 filers reported holding VENTYX BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $811,189 | +9.8% | 23,357 | +3.7% | 0.01% | 0.0% |
Q2 2023 | $738,853 | +83.3% | 22,526 | +87.2% | 0.01% | +66.7% |
Q1 2023 | $403,173 | +4.2% | 12,035 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $386,758 | +4.2% | 11,795 | +10.8% | 0.00% | 0.0% |
Q3 2022 | $371,000 | +189.8% | 10,641 | +1.4% | 0.00% | +200.0% |
Q2 2022 | $128,000 | +82.9% | 10,490 | +102.3% | 0.00% | – |
Q1 2022 | $70,000 | -36.4% | 5,185 | -6.6% | 0.00% | -100.0% |
Q4 2021 | $110,000 | – | 5,551 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |